{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:32:57Z","timestamp":1793082777570,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","award":["IPP: 832-166-2025"],"award-info":[{"award-number":["IPP: 832-166-2025"]}],"id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejphar.2026.179392","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:58:02Z","timestamp":1791356282000},"page":"179392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Celastrol attenuates testosterone-induced benign prostatic hyperplasia by modulating the PTEN\/PI3K\/AKT pathway"],"prefix":"10.1016","volume":"1037","author":[{"given":"Bashaer E.","family":"Alsayegh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmohsin J.","family":"Alamoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0241-9345","authenticated-orcid":false,"given":"Khaleda A.","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama M.","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf B.","family":"Abdel-Naim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3742-7879","authenticated-orcid":false,"given":"Rawan H.","family":"Hareeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179392_bib40","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ucl.2016.04.012","article-title":"Review of prostate anatomy and embryology and the etiology of Benign Prostatic Hyperplasia","volume":"43","author":"Aaron","year":"2016","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.ejphar.2026.179392_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4389484","article-title":"2-Methoxyestradiol attenuates testosterone-induced benign prostate hyperplasia in rats through inhibition of HIF-1 \u03b1\/TGF- \u03b2\/Smad2 axis","author":"Abdel-Naim","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2026.179392_bib2","doi-asserted-by":"crossref","first-page":"9937","DOI":"10.1007\/s00210-026-05044-y","article-title":"Uroprotective effect of diarylpropionitrile versus finasteride on rat model of testosterone-induced prostatic hyperplasia","volume":"399","author":"Ali","year":"2026","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ejphar.2026.179392_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/a-2801-8227","article-title":"Counteractive effects of diarylpropionitrile on testosterone-induced benign prostatic hyperplasia in rats via targeting key androgenic, angiogenic, proliferative, and inflammatory mechanisms","volume":"76","author":"Ali","year":"2026","journal-title":"Drug Res."},{"key":"10.1016\/j.ejphar.2026.179392_bib4","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00210-014-1040-y","article-title":"Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia: emphasis on PTEN, HIF-1\u03b1, and NF-\u03baB","volume":"387","author":"Atawia","year":"2014","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ejphar.2026.179392_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajur.2017.06.004","article-title":"Epidemiology of clinical benign prostatic hyperplasia","volume":"4","author":"Bin","year":"2017","journal-title":"Asian Journal of Urology"},{"key":"10.1016\/j.ejphar.2026.179392_bib6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1039\/c9tx00141g","article-title":"Celastrol pretreatment as a therapeutic option against cisplatin-induced nephrotoxicity","volume":"8","author":"Boran","year":"2019","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.ejphar.2026.179392_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MOU.0b013e32835abd4a","article-title":"Correlation between benign prostatic hyperplasia and inflammation","volume":"23","author":"Bostanci","year":"2013","journal-title":"Curr. Opin. Urol."},{"key":"10.1016\/j.ejphar.2026.179392_bib8","first-page":"1","article-title":"A mechanistic overview of triptolide and celastrol, natural products from Tripterygium wilfordii hook F","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179392_bib9","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20210477","article-title":"Incaspitolide A extracted from Carpesium cernuum induces apoptosis in vitro via the PI3K\/AKT pathway in benign prostatic hyperplasia","volume":"41","author":"Chen","year":"2021","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.ejphar.2026.179392_bib10","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00345-023-04357-4","article-title":"The effect of 5-\u03b1 reductase inhibitor on Th1, Th2, and Th17 cell-related inflammatory response in BPH","volume":"41","author":"Chu","year":"2023","journal-title":"World J. Urol."},{"key":"10.1016\/j.ejphar.2026.179392_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules26237141","article-title":"Treatment of benign prostatic hyperplasia by natural drugs","volume":"26","author":"Csik\u00f3s","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2026.179392_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1677\/erc.0.0070115","article-title":"PTEN, a unique tumor suppressor gene","volume":"7","author":"Dahia","year":"2000","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ejphar.2026.179392_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-med-063014-123902","article-title":"Management of benign prostatic hyperplasia","volume":"67","author":"Eric","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejphar.2026.179392_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00018-023-04940-3","article-title":"Reciprocal negative feedback regulation of ATF6\u03b1 and PTEN promotes prostate cancer progression","volume":"80","author":"Feng","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2026.179392_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/bju.12118","article-title":"The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH)","volume":"112","author":"Gandaglia","year":"2013","journal-title":"BJU Int."},{"key":"10.1016\/j.ejphar.2026.179392_bib16","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1210\/jc.2018-01832","article-title":"Effect of testosterone on FGF2, MRF4, and myostatin in hypogonadotropic hypogonadism: relevance to muscle growth","volume":"104","author":"Ghanim","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2026.179392_bib17","first-page":"1","article-title":"Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress","volume":"8","author":"Gu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179392_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3949\/ccjm.91a.23027","article-title":"Medical management of benign prostatic hyperplasia","volume":"91","author":"Haile","year":"2024","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.ejphar.2026.179392_bib19","doi-asserted-by":"crossref","first-page":"E678","DOI":"10.1152\/ajpendo.00157.2020","article-title":"Testosterone supplementation upregulates androgen receptor expression and translational capacity during severe energy deficit","volume":"319","author":"Howard","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2026.179392_bib20","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4093\/dmj.2019.0124","article-title":"Effects of microbiota on the treatment of obesity with the natural product celastrol in rats","volume":"44","author":"Hu","year":"2020","journal-title":"Diabetes Metab. J"},{"key":"10.1016\/j.ejphar.2026.179392_bib21","first-page":"212","volume":"vol. 1","author":"Jarvis","year":"2015"},{"key":"10.1016\/j.ejphar.2026.179392_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10565-025-10079-7","article-title":"Celastrol modulates IRS1 expression to alleviate ovarian aging and to enhance follicular development","volume":"41","author":"Jiang","year":"2025","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ejphar.2026.179392_bib23","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1007\/s10495-011-0629-6","article-title":"Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K\/Akt signaling pathways","volume":"16","author":"Kannaiyan","year":"2011","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejphar.2026.179392_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0236879","article-title":"Protective effects of combination of stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5\u03b1- reductase type 2 and induced cell apoptosis","volume":"15","author":"Karunasagara","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179392_bib26","first-page":"1","article-title":"Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: a meta-analysis","volume":"13","author":"Kim","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179392_bib25","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.bbrc.2012.07.165","article-title":"Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells","volume":"425","author":"Kim","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2026.179392_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pop.2019.02.003","article-title":"Benign prostatic hyperplasia","volume":"46","author":"Langan","year":"2019","journal-title":"Prim. Care Clin. Off. Pract."},{"key":"10.1016\/j.ejphar.2026.179392_bib28","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/bju.15286","article-title":"The rising worldwide impact of benign prostatic hyperplasia","volume":"127","author":"Launer","year":"2021","journal-title":"BJU Int."},{"key":"10.1016\/j.ejphar.2026.179392_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2015.00320","article-title":"Celastrol ameliorates ulcerative colitis-related colorectal cancer in mice via suppressing inflammatory responses and epithelial-mesenchymal transition","volume":"6","author":"Lin","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179392_bib30","first-page":"2703","article-title":"Roles of autophagy in androgen-induced benign prostatic hyperplasia in castrated rats","volume":"15","author":"Liu","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2026.179392_bib31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ejphar.2026.179392_bib32","first-page":"1","volume":"vol. 20","author":"Lloyd","year":"2020"},{"key":"10.1016\/j.ejphar.2026.179392_bib33","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/med.21751","article-title":"Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone-methide triterpenoid celastrol","volume":"41","author":"Lu","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejphar.2026.179392_bib34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000496289","article-title":"Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: a mini-review","volume":"65","author":"Madersbacher","year":"2019","journal-title":"Gerontology"},{"key":"10.1016\/j.ejphar.2026.179392_bib35","first-page":"843","article-title":"Current treatment for benign prostatic hyperplasia","volume":"117","author":"Miernik","year":"2020","journal-title":"Deutsches Arzteblatt International"},{"key":"10.1016\/j.ejphar.2026.179392_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000366210","article-title":"Oxidative stress in benign prostatic hyperplasia: a systematic review","volume":"94","author":"Minciullo","year":"2015","journal-title":"Urol. Int."},{"key":"10.1016\/j.ejphar.2026.179392_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms17081311","article-title":"Apoptotic pathways linked to endocrine system as potential therapeutic targets for benign prostatic hyperplasia","volume":"17","author":"Minutoli","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179392_bib38","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.biopha.2018.11.051","article-title":"Molecular modulators of celastrol as the keystones for its diverse pharmacological activities","volume":"109","author":"Ng","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179392_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/2090598X.2021.2010451","article-title":"Prevalence of benign prostatic hyperplasia among the adult general population of five Middle Eastern countries: results of the SNAPSHOT programme","volume":"20","author":"Noweir","year":"2022","journal-title":"Arab Journal of Urology"},{"key":"10.1016\/j.ejphar.2026.179392_bib41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.juro.2007.03.103","article-title":"Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems","volume":"178","author":"Parsons","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2026.179392_bib42","first-page":"139","article-title":"Oxidative stress promotes benign prostatic hyperplasia","volume":"176","author":"Paz","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2026.179392_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.46471\/gigabyte.14","article-title":"The genome of Tripterygium wilfordii and characterization of the celastrol biosynthesis pathway","volume":"2021","author":"Pei","year":"2021","journal-title":"Gigabyte"},{"key":"10.1016\/j.ejphar.2026.179392_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0293682","article-title":"Diacerein provokes apoptosis, improves redox balance, and downregulates PCNA and TNF-\u03b1 in a rat model of testosterone-induced benign prostatic hyperplasia: a new noninvasive approach","volume":"18","author":"Rasheed","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179392_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/ajpheart.00465.2005","article-title":"Testosterone augments endotoxin-mediated cerebrovascular inflammation in Male rats","volume":"289","author":"Razmara","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2026.179392_bib46","first-page":"1141","article-title":"A miRNA-21-Mediated PTEN\/Akt\/NF-\u03baB axis promotes chronic obstructive pulmonary disease pathogenesis","volume":"19","author":"Sai","year":"2024","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.ejphar.2026.179392_bib47","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cell.2008.04.013","article-title":"Tenets of PTEN tumor suppression","volume":"133","author":"Salmena","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.179392_bib48","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.neuint.2006.05.003","article-title":"Effects of testosterone on brain mRNA levels of steroid 5alpha-reductase isozymes in early postnatal life of rat","volume":"49","author":"S\u00e1nchez","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ejphar.2026.179392_bib49","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.2147\/IJN.S93752","article-title":"Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment","volume":"10","author":"Sanna","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejphar.2026.179392_bib50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000357683","article-title":"Celastrol induces apoptosis of gastric cancer cells by miR-21 inhibiting PI3K\/Akt-NF-and kappa;b signaling pathway","volume":"93","author":"Sha","year":"2014","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2026.179392_bib51","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/01926230252824761","article-title":"Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies","volume":"30","author":"Shackelford","year":"2002","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ejphar.2026.179392_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113474","article-title":"Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1\u03b1 pathway","volume":"220","author":"Shang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.179392_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058391","article-title":"Celastrol suppresses tumor cell growth through targeting an AR-ERG-NF-\u03baB pathway in TMPRSS2\/ERG fusion gene expressing prostate cancer","volume":"8","author":"Shao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179392_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.558741","article-title":"Celastrol: a review of useful strategies overcoming its limitation in anticancer application","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179392_bib55","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.3390\/ijms21124507","article-title":"The PI3K-AKT-mTOR pathway and prostate cancer: at the crossroads of AR, MAPK, and WNT signaling","volume":"21","author":"Shorning","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179392_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114705","article-title":"A comprehensive review on celastrol, triptolide and triptonide: insights on their pharmacological activity, toxicity, combination therapy, new dosage form and novel drug delivery routes","volume":"162","author":"Song","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179392_bib57","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/13685538.2018.1519014","article-title":"Over expression of PI3K-AkT reduces apoptosis and increases prostate size in benign prostatic hyperplasia","volume":"23","author":"Sreenivasulu","year":"2020","journal-title":"Aging Male"},{"key":"10.1016\/j.ejphar.2026.179392_bib58","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2353\/ajpath.2007.070199","article-title":"Sex hormones induce direct epithelial and inflammation-mediated oxidative\/nitrosative stress that favors prostatic carcinogenesis in the noble rat","volume":"171","author":"Tam","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2026.179392_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7958316","article-title":"Review of the roles and interaction of androgen and inflammation in benign prostatic hyperplasia","volume":"2020","author":"Tong","year":"2020","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ejphar.2026.179392_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0035-1565100","article-title":"Sexual dysfunction related to drugs: a critical ReviewPart V: \u03b1-Blocker and 5-ARI drugs","volume":"49","author":"Torre","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ejphar.2026.179392_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-016-0418-8","article-title":"Oxidative stress in prostate hyperplasia and carcinogenesis","volume":"35","author":"Udensi","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2026.179392_bib62","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3390\/ijms19041137","article-title":"Rhodobacter sphaeroides extract LycogenTM Attenuates testosterone-induced benign prostate hyperplasia in rats","volume":"19","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179392_bib63","first-page":"2515","article-title":"Celastrol suppresses the proliferation of lung adenocarcinoma cells by regulating microRNA-24 and microRNA-181b","volume":"15","author":"Yan","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejphar.2026.179392_bib64","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.freeradbiomed.2021.06.020","article-title":"Up-regulation of heme oxygenase-1 by celastrol alleviates oxidative stress and vascular calcification in chronic kidney disease","volume":"172","author":"Yang","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179392_bib65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4111\/kju.2012.53.3.139","article-title":"Benign prostatic hyperplasia: from bench to clinic","volume":"53","author":"Yoo","year":"2012","journal-title":"Korean Journal of Urology"},{"key":"10.1016\/j.ejphar.2026.179392_bib66","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12013-022-01064-6","article-title":"The protective role of celastrol in renal ischemia-reperfusion injury by activating Nrf2\/HO-1, PI3K\/AKT signaling pathways, modulating NF-\u03bab signaling pathways, and inhibiting ERK phosphorylation","volume":"80","author":"Younis","year":"2022","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2026.179392_bib67","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.3892\/or.2015.4124","article-title":"Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway","volume":"34","author":"Yu","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2026.179392_bib68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/and.12420","article-title":"Oxidative stress in benign prostate hyperplasia","volume":"48","author":"Zabaiou","year":"2016","journal-title":"Andrologia"},{"key":"10.1016\/j.ejphar.2026.179392_bib70","first-page":"1","article-title":"Neuroprotective effects of celastrol on transient global cerebral ischemia rats via regulating HMGB1\/NF-\u03baB signaling pathway","volume":"14","author":"Zhang","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179392_bib69","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/jop.2018.0092","article-title":"Celastrol ameliorates inflammation in human retinal pigment epithelial cells by suppressing NF-\u03baB signaling","volume":"35","author":"Zhang","year":"2019","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2026.179392_bib71","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4103\/aja202171","article-title":"Sexual, physical, and overall adverse effects in patients treated with 5\u03b1-reductase inhibitors: a systematic review and meta-analysis","volume":"24","author":"Zhang","year":"2022","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.ejphar.2026.179392_bib73","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2147\/DDDT.S402503","article-title":"Network pharmacology and experimental validation to explore that celastrol targeting PTEN is the potential mechanism of Tripterygium wilfordii (L\u00e9v.) hutch against IgA nephropathy","volume":"17","author":"Zhao","year":"2023","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2026.179392_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpls.2017.02221","article-title":"Genetic transformation system for woody plant Tripterygium wilfordii and its application to product natural celastrol","volume":"8","author":"Zhao","year":"2018","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.ejphar.2026.179392_bib74","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.3892\/mmr.2015.3206","article-title":"Qianliening capsules influence the apoptosis of benign prostatic hyperplasia epithelial-1 cells by regulating the extracellular matrix","volume":"11","author":"Zhou","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2026.179392_bib75","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/cam4.2719","article-title":"Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN\/PI3K\/Akt pathway","volume":"9","author":"Zhu","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.ejphar.2026.179392_bib78","first-page":"1","article-title":"PI3K\/AKT\/mTOR-Targeted therapy for breast cancer","author":"Zhu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.179392_bib76","first-page":"1","article-title":"Celastrol suppresses glioma vasculogenic mimicry formation and angiogenesis by blocking the PI3K\/Akt\/mTOR signaling pathway","volume":"11","author":"Zhu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179392_bib77","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.apsb.2020.12.008","article-title":"Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice","volume":"11","author":"Zhu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2026.179392_bib79","first-page":"933","article-title":"Celastrol inhibits prostaglandin E2-induced proliferation and osteogenic differentiation of fibroblasts isolated from ankylosing spondylitis hip tissues in vitro","volume":"10","author":"Zou","year":"2016","journal-title":"Drug Des. Dev. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:37:14Z","timestamp":1793079434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926008745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":79,"alternative-id":["S0014299926008745"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179392","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celastrol attenuates testosterone-induced benign prostatic hyperplasia by modulating the PTEN\/PI3K\/AKT pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"179392"}}